UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 8-K
Current Report
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): February 15, 2005
MACROPORE BIOSURGERY, INC.
(Exact name of registrant as specified in its charter)
Delaware | | 000-32501 | | 33-0827593 |
(State or Other Jurisdiction of
Incorporation) | | (Commission File
Number) | | (I.R.S. Employer Identification
Number) |
6740 Top Gun Street, San Diego, California 92121
(Address of principal executive offices, with zip code)
(858) 458-0900
(Registrant’s telephone number, including area code)
n/a
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 5.02 Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers.
Paul Hawran, Executive Vice President and Chief Financial Officer of Neurocrine Biosciences, Inc., was elected as a member of the Board of Directors of MacroPore Biosurgery, Inc., effective February 15, 2005. A copy of the press release announcing Mr. Hawran’s election is attached hereto as Exhibit 99.1.
Item 9.01 Financial Statements and Exhibits
(c) Exhibits
Exhibit 99.1 Press release issued by MacroPore Biosurgery, Inc. on February 17, 2005.
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| MACROPORE BIOSURGERY, INC. |
| | | |
| | | |
Date: February 22, 2005 | By: | /s/ | CHRISTOPHER J. CALHOUN | |
| | Christopher J. Calhoun |
| | Chief Executive Officer |
| | | | | |
3
EXHIBIT INDEX
Exhibit
Number | | Description of Document |
99.1 | | Press release issued by MacroPore Biosurgery, Inc. on February 17, 2005. |
4
